Article Details
Retrieved on: 2024-05-08 22:08:55
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... antibody targeting DLL3 and CD47; atezolizumab (TECENTRIQ®) is Roche's anti-PD-L1 monoclonal antibody; The clinical supply agreement will focus on ...
Article found on: www.morningstar.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here